- In October 2024, Bruker Corporation unveiled the creation of a new division, Bruker Spatial Biology, which will provide a wide range of comprehensive solutions for spatial biology. The division aims to advance biomedical research by offering a suite of spatial biology instruments, assays, software, data analytics, and contract research organization (CRO) services, focusing on the industry's most promising technologies
- In April 2024, Vizgen, Inc. introduced the MERSCOPE Ultra Platform and MERFISH 2.0 chemistry at the AACR 2024 Annual Meeting. These advanced tools are specifically designed to support both basic and translational research. The MERSCOPE Ultra offers an optimal combination of imaging area and throughput, making it a cutting-edge platform for spatial transcriptomics imaging
- In May 2023, Bio-Techne unveiled an expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio with the introduction of a multi-omic workflow for the Standard BioTools Hyperion Imaging System. The new RNAscope HiPlex12 Flex Kit allows for the visualization of highly multiplexed RNA biomarkers using the Hyperion XTi or earlier versions of the Hyperion Imaging System
- In November 2021, Illumina, Inc. and Genetic Alliance launched the iHope Genetic Health program, designed to provide whole-genome sequencing (WGS) to tens of thousands of patients worldwide affected by genetic diseases. Through this initiative, Illumina will support Genetic Alliance, a global nonprofit dedicated to advancing genetics for human health, in establishing networks of clinics and laboratories equipped with cutting-edge genomic technology to deliver precision diagnoses for patients with rare genetic conditions
- In August 2020, Horizon Discovery Group plc expanded its CRISPR screening services portfolio by adding single-cell RNA sequencing-linked pooled CRISPR screening. This new platform provides high-quality screening data and valuable biological insights to help address key challenges in target identification and validation
Frequently Asked Questions
The market is segmented based on Global Spatial Genomics and Transcriptomics Market Segmentation, By Type (Instruments, Services, Consumables and Software), Type of Sample analyzed (DNA, RNA and Proteins), Application (Drug Discover & Development, Proteomics & Genomics, Disease Identification, Others), End User (Academic Research Institutes, Pharmaceutical Companies and Contract Research Organisations), Research Areas (Oncology, Immunology, Neurology, Infectious and Others) – Industry Trends and Forecast to 2032
.
The Global Spatial Genomics And Transcriptomics Market size was valued at USD 1.22 USD Billion in 2024.
The Global Spatial Genomics And Transcriptomics Market is projected to grow at a CAGR of 21.3% during the forecast period of 2025 to 2032.
The major players operating in the market include 10x Genomics ,Advanced Cell DiagnosticsInc. ,Akoya BiosciencesInc. ,Bio-Rad LaboratoriesInc. ,Bio-Techne ,Bruker Spatial BiologyInc. ,Canopy Biosciences ,Cantata Bio ,Danaher Corporation ,IlluminaInc. ,MacrogenInc. ,Miltenyi Biotec ,NateraInc. ,Revvity Discovery Limited ,S2 GenomicsInc. ,Seven Bridges Genomics ,Standard BioTools ,VeracyteInc. ,Visiopharm A/S ,Vizgen Inc. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Italy, Spain, Germany, Denmark, Sweden, Norway, Rest of Europe in Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Kuwait, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
